Pennsylvania 10th State to Fully Adopt NUMP

The Racing Medication and Testing Consortium (RMTC) announced Aug. 9 that Pennsylvania has become the 10th state to pass the National Uniform Medication Program (NUMP) in its entirety.

With the adoption of NUMP by the Pennsylvania Racing Commission July 27, the state is the latest racing jurisdiction to implement all or portions of the program in 2016.

Developed by the RMTC and enacted as model rules by the Association of Racing Commissioners International, the program includes a controlled therapeutic substances list, third-party administration of furosemide, a multiple medication violation penalty system, and a requirement for laboratory accreditation and participation in an industry external quality assurance program. 

States that have adopted the program in full are Arkansas, Delaware, Indiana, Maryland, Massachusetts, North Dakota, New Jersey, Pennsylvania, Virginia, and West Virginia. Once the New York laboratory receives full RMTC laboratory accreditation as anticipated this fall, NUMP will then be adopted in 11 jurisdictions representing 39% of U.S. Thoroughbred pari-mutuel handle, according to the RMTC.

"RMTC vice chair and Thoroughbred Horsemen's Association chief executive officer Alan Foreman helped facilitate adoption of the National Uniform Medication Program in Pennsylvania," said RMTC executive director Dionne Benson in an RMTC release. "It continues to be a top priority for RMTC staff and officers to travel to commissions across the country and meet with horsemen groups in order to assist in this process. While we are encouraged by the progress, we look forward to more adoptions by commissions around the country before the year's end."

The MMV penalty system, which was the final component that the Pennsylvania commission needed to adopt, creates a tracking system for an individual's violations and provides enhanced penalties for those who accumulate multiple medication violations, regardless of the jurisdiction in which they occur.

In implementing the MMV penalty system, Pennsylvania joins New York, which also adopted it in 2016, as well as Arkansas, Colorado, Delaware, Indiana, Maryland, Massachusetts, New Jersey, North Dakota, Virginia, and West Virginia. These states represent 40% of total U.S. Thoroughbred pari-mutuel handle. 

Over the past year, racing states adopting the Controlled Therapeutic Substances list have increased from 15 to 20. These states represent 94% of the national Thoroughbred pari-mutuel handle. The CTS list establishes strict regulatory thresholds and provides withdrawal times for 30 specific medications for the routine treatment of illness or injury in the horse. Florida, Idaho, Illinois, Louisiana, and Texas have joined Arkansas, California, Delaware, Indiana, Kentucky, Maryland, Massachusetts, Minnesota, New Jersey, New Mexico, New York, North Dakota, Pennsylvania, Virginia, and West Virginia in regulating therapeutic medications using the medication schedule.

"We're thrilled that the CTS list has been adopted by every major racing state in the country," said Benson in an RMTC release. "It's proved to be vitally important to protecting the welfare of the racing horse; in fact, veterinary experts have noted a link between the administration guidelines provided for corticosteroid injections and a reduction in racing injuries." 

Commissions requiring third-party administration of furosemide (commonly referred to as Lasix) on race day have risen from 16 to 19. This policy, which is a key component of NUMP, effectively restricts the access of private veterinarians to horses on race day. The California Horse Racing Board, which approved the policy earlier this summer, as well as commissions in Idaho and Montana, have joined Arkansas, Colorado, Delaware, Florida, Indiana, Kentucky, Maine, Maryland, Massachusetts, Minnesota, New Jersey, New York, North Dakota, Pennsylvania, Virginia and West Virginia in implementing the regulation. These states represent 85% of U.S. Thoroughbred pari-mutuel handle. 

When the Texas Veterinary Medical Diagnostic Laboratory at Texas A&M University received RMTC accreditation last October, Texas became the 27th horse racing state to use an RMTC-accredited lab and external quality assurance program for its equine drug and medication testing services; up from 24 one year ago. Texas, Montana and Nevada  join Arizona, Arkansas, California, Colorado, Delaware, Idaho, Indiana, Kentucky, Maine, Maryland, Massachusetts, Minnesota, Nebraska, New Jersey, New Mexico, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Washington, Virginia, West Virginia, and Wyoming in solely using RMTC-accredited lab testing services.

The laboratory accreditation and quality assurance programs are modeled on gold standard human protocols established by the World Anti-Doping Agency and ensure that all laboratories are operating at the same high level of proficiency. This consistency enables uniformity and strengthens both the integrity of racing and the safety of its human and equine athletes. In addition to the New York laboratory being eligible for full accreditation this fall, the Illinois laboratory will be eligible for accreditation by the winter. These accredited and soon-to-be accredited laboratories provide testing of samples for 29 racing states representing 78% of the U.S. Thoroughbred pari-mutuel handle. 

"We've been pleased to see adoptions of all four components of the program by numerous commissions across the country in the last year," said Alex Waldrop, chairman of the RMTC and president of the NTRA. "However, it is absolutely imperative that the remaining 21 Thoroughbred racing commissions adopt the reforms in their entirely without further delay.

"The RMTC and its expert staff and officers continually make themselves available to assist regulators and racing participants seeking to implement the program in their state, and to further educate the industry on the critical components of this initiative. We must keep building on the momentum of this movement and fulfill our goal to see the complete adoption of the program."